A carregar...
Clinical Use of Tobramycin Inhalation Solution (TOBI(®)) Shows Sustained Improvement in FEV1 in Cystic Fibrosis
OBJECTIVES: Tobramycin inhalation solution (TIS; TOBI(®)) has improved forced expiratory volume in 1 second (FEV(1)) in cystic fibrosis (CF) trials. Using data from the Epidemiologic Study of CF (ESCF), we assessed the change in level and trend of FEV(1) % predicted (pred) over a 2-year period assoc...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4038134/ https://ncbi.nlm.nih.gov/pubmed/24019211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ppul.22874 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|